Royalty Pharma PLCNASDAQ:RPRX
- LAST PRICE25.4800
- TODAY'S CHANGE (%)-0.4400 (-1.6975%)
- Bid / Lots25.4700/ 4
- Ask / Lots25.4800/ 1
- Open / Previous Close25.8400 / 25.9200
- Day Range
- 52 Week Range
- Volume893,710
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | RPRX |
|---|---|---|
| 09:32 ET | 27931 | 25.76 |
| 09:34 ET | 600 | 25.71 |
| 09:36 ET | 5376 | 25.71 |
| 09:38 ET | 3931 | 25.82 |
| 09:39 ET | 1720 | 25.82 |
| 09:41 ET | 4623 | 25.72 |
| 09:43 ET | 5229 | 25.75 |
| 09:45 ET | 9360 | 25.745 |
| 09:48 ET | 4850 | 25.68 |
| 09:50 ET | 7319 | 25.64 |
| 09:52 ET | 3360 | 25.6495 |
| 09:54 ET | 3620 | 25.62 |
| 09:56 ET | 2603 | 25.59 |
| 09:57 ET | 3158 | 25.61 |
| 09:59 ET | 8398 | 25.68 |
| 10:01 ET | 5920 | 25.575 |
| 10:03 ET | 11040 | 25.55 |
| 10:06 ET | 13836 | 25.535 |
| 10:08 ET | 4768 | 25.516 |
| 10:10 ET | 25924 | 25.525 |
| 10:12 ET | 19260 | 25.515 |
| 10:14 ET | 7551 | 25.56 |
| 10:15 ET | 5952 | 25.49 |
| 10:17 ET | 13991 | 25.505 |
| 10:19 ET | 5141 | 25.5 |
| 10:21 ET | 4382 | 25.505 |
| 10:24 ET | 1600 | 25.515 |
| 10:26 ET | 7155 | 25.5 |
| 10:28 ET | 3621 | 25.51 |
| 10:30 ET | 3516 | 25.47 |
| 10:32 ET | 4440 | 25.49 |
| 10:33 ET | 2017 | 25.515 |
| 10:35 ET | 3217 | 25.505 |
| 10:37 ET | 1236 | 25.48 |
| 10:39 ET | 5455 | 25.4492 |
| 10:42 ET | 7625 | 25.445 |
| 10:44 ET | 6946 | 25.455 |
| 10:46 ET | 15279 | 25.54 |
| 10:48 ET | 11471 | 25.51 |
| 10:50 ET | 11709 | 25.5107 |
| 10:51 ET | 5523 | 25.52 |
| 10:53 ET | 3175 | 25.5 |
| 10:55 ET | 8075 | 25.52 |
| 10:57 ET | 3750 | 25.54 |
| 11:00 ET | 3940 | 25.565 |
| 11:02 ET | 3663 | 25.53 |
| 11:04 ET | 2510 | 25.55 |
| 11:06 ET | 3004 | 25.58 |
| 11:08 ET | 4234 | 25.615 |
| 11:09 ET | 4172 | 25.59 |
| 11:11 ET | 5576 | 25.5735 |
| 11:13 ET | 5899 | 25.59 |
| 11:15 ET | 2538 | 25.55 |
| 11:18 ET | 5284 | 25.54 |
| 11:20 ET | 3147 | 25.55 |
| 11:22 ET | 5139 | 25.54 |
| 11:24 ET | 1303 | 25.54 |
| 11:26 ET | 3195 | 25.525 |
| 11:27 ET | 9665 | 25.605 |
| 11:29 ET | 2788 | 25.59 |
| 11:31 ET | 3853 | 25.61 |
| 11:33 ET | 6608 | 25.605 |
| 11:36 ET | 1959 | 25.615 |
| 11:38 ET | 3961 | 25.615 |
| 11:40 ET | 22109 | 25.575 |
| 11:42 ET | 4874 | 25.59 |
| 11:44 ET | 4053 | 25.6 |
| 11:45 ET | 4850 | 25.6 |
| 11:47 ET | 3233 | 25.615 |
| 11:49 ET | 1700 | 25.615 |
| 11:51 ET | 4828 | 25.62 |
| 11:54 ET | 1908 | 25.615 |
| 11:56 ET | 2460 | 25.605 |
| 11:58 ET | 3889 | 25.57 |
| 12:00 ET | 6964 | 25.57 |
| 12:02 ET | 8740 | 25.55 |
| 12:03 ET | 3372 | 25.52 |
| 12:05 ET | 1450 | 25.53 |
| 12:07 ET | 4220 | 25.58 |
| 12:09 ET | 12497 | 25.5447 |
| 12:12 ET | 8747 | 25.54 |
| 12:14 ET | 2749 | 25.535 |
| 12:16 ET | 2500 | 25.54 |
| 12:18 ET | 4211 | 25.56 |
| 12:20 ET | 1687 | 25.545 |
| 12:21 ET | 5078 | 25.52 |
| 12:23 ET | 2702 | 25.53 |
| 12:25 ET | 2818 | 25.54 |
| 12:27 ET | 3400 | 25.525 |
| 12:30 ET | 3051 | 25.505 |
| 12:32 ET | 7342 | 25.5 |
| 12:34 ET | 3860 | 25.515 |
| 12:36 ET | 4872 | 25.505 |
| 12:38 ET | 4727 | 25.505 |
| 12:39 ET | 1590 | 25.515 |
| 12:41 ET | 5396 | 25.505 |
| 12:43 ET | 16934 | 25.495 |
| 12:45 ET | 400 | 25.49 |
| 12:48 ET | 1931 | 25.495 |
| 12:50 ET | 700 | 25.495 |
| 12:52 ET | 2292 | 25.49 |
| 12:54 ET | 5460 | 25.49 |
| 12:56 ET | 1100 | 25.5 |
| 12:57 ET | 3441 | 25.485 |
| 12:59 ET | 1365 | 25.48 |
| 01:01 ET | 4004 | 25.465 |
| 01:03 ET | 2144 | 25.47 |
| 01:06 ET | 938 | 25.475 |
| 01:08 ET | 1502 | 25.46 |
| 01:10 ET | 1006 | 25.465 |
| 01:12 ET | 5349 | 25.465 |
| 01:14 ET | 5113 | 25.435 |
| 01:15 ET | 3610 | 25.44 |
| 01:17 ET | 1162 | 25.445 |
| 01:19 ET | 2343 | 25.435 |
| 01:21 ET | 3938 | 25.45 |
| 01:24 ET | 3778 | 25.455 |
| 01:26 ET | 813 | 25.4589 |
| 01:28 ET | 3338 | 25.46 |
| 01:30 ET | 1406 | 25.46 |
| 01:32 ET | 1607 | 25.45 |
| 01:33 ET | 3427 | 25.43 |
| 01:35 ET | 2200 | 25.45 |
| 01:37 ET | 600 | 25.435 |
| 01:39 ET | 500 | 25.43 |
| 01:42 ET | 800 | 25.435 |
| 01:44 ET | 10958 | 25.49 |
| 01:46 ET | 10246 | 25.48 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Royalty Pharma PLC | 15.5B | 14.3x | +1.83% |
Amneal Pharmaceuticals Inc | 2.1B | -11.9x | --- |
Catalent Inc | 10.2B | -8.8x | --- |
Jazz Pharmaceuticals PLC | 6.5B | 20.8x | -3.53% |
Mallinckrodt PLC | 1.6M | 0.0x | --- |
Prestige Consumer Healthcare Inc | 3.4B | 16.3x | --- |
Company Information
Royalty Pharma plc is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The Company collaborates with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio consists of royalties on over 35 commercial products, including Vertex’s Trikafta, GSK’s Trelegy, Roche’s Evrysdi, Johnson & Johnson’s Tremfya, Biogen’s Tysabri and Spinraza, AbbVie and Johnson & Johnson’s Imbruvica, Astellas and Pfizer’s Xtandi, Novartis’ Promacta, Pfizer’s Nurtec ODT and Gilead’s Trodelvy, and 14 development-stage product candidates. Its development-stage product candidates include Aficamten, Ampreloxetine, BCX10013, MK-8189, Ecopipam, Olpasiran, Pelabresib, KarXT, Pelacarsen, Seltorexant, Trontinemab, TEV-'749, Tulmimetostat and Vanzacaftor. Its subsidiaries include Royalty Pharma Holdings Ltd., Royalty Pharma Investments and others.
Contact Information
- Headquarters
- 110 East 59th StreetNEW YORK, NY, United States 10022
- Phone
- 212-883-0200
- Fax
- ---
Executives
- Chairman of the Board, Chief Executive Officer
- Pablo Legorreta
- Vice Chairman, Executive Vice President
- Christopher Hite
- Chief Financial Officer, Executive Vice President
- Terrance Coyne
- Executive Vice President - Investments and Chief Legal Officer
- George Lloyd
- Executive Vice President - Research and Investments
- Marshall Urist
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $15.5B |
|---|---|
Revenue (TTM) | $2.2B |
Shares Outstanding | 597.4M |
Dividend Yield | 3.30% |
Annual Dividend Rate | 0.8400 USD |
Ex-Dividend Date | 05-16-24 |
Pay Date | 06-14-24 |
Beta | 0.46 |
EPS | $1.78 |
Book Value | $14.61 |
P/E Ratio | 14.3x |
Price/Sales (TTM) | 6.9 |
Price/Cash Flow (TTM) | 13.0x |
Operating Margin | 41.96% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
